|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase inhibitor/hydrolase
|
 |
|
Title:
|
 |
Crystal structure of cysteine protease inhibitor, chagasin, in complex with human cathepsin l
|
|
Structure:
|
 |
Chagasin. Chain: a. Synonym: cysteine protease inhibitor. Engineered: yes. Cathepsin l. Chain: b. Fragment: residues 1-220. Synonym: cysteine protease, major excreted protein, mep. Engineered: yes.
|
|
Source:
|
 |
Trypanosoma cruzi. Organism_taxid: 5693. Expressed in: escherichia coli bl21. Expression_system_taxid: 511693. Homo sapiens. Human. Organism_taxid: 9606. Expressed in: pichia pastoris. Expression_system_taxid: 4922.
|
|
Resolution:
|
 |
|
1.75Å
|
R-factor:
|
0.150
|
R-free:
|
0.188
|
|
|
Authors:
|
 |
I.Redzynia,G.Bujacz,A.Ljunggren,M.Jaskolski,M.Abrahamson
|
Key ref:
|
 |
A.Ljunggren
et al.
(2007).
Crystal structure of the parasite protease inhibitor chagasin in complex with a host target cysteine protease.
J Mol Biol,
371,
137-153.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
31-Oct-06
|
Release date:
|
24-Jul-07
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chain B:
E.C.3.4.22.15
- cathepsin L.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Specificity close to that of papain. As compared to cathepsin B, cathepsin L exhibits higher activity towards protein substrates, but has little activity on Z-Arg-Arg-NHMec, and no peptidyl-dipeptidase activity.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
371:137-153
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of the parasite protease inhibitor chagasin in complex with a host target cysteine protease.
|
|
A.Ljunggren,
I.Redzynia,
M.Alvarez-Fernandez,
M.Abrahamson,
J.S.Mort,
J.C.Krupa,
M.Jaskolski,
G.Bujacz.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Chagasin is a protein produced by Trypanosoma cruzi, the parasite that causes
Chagas' disease. This small protein belongs to a recently defined family of
cysteine protease inhibitors. Although resembling well-known inhibitors like the
cystatins in size (110 amino acid residues) and function (they all inhibit
papain-like (C1 family) proteases), it has a unique amino acid sequence and
structure. We have crystallized and solved the structure of chagasin in complex
with the host cysteine protease, cathepsin L, at 1.75 A resolution. An
inhibitory wedge composed of three loops (L2, L4, and L6) forms a number of
contacts responsible for high-affinity binding (K(i), 39 pM) to the enzyme. All
three loops interact with the catalytic groove, with the central loop L2
inserted directly into the catalytic center. Loops L4 and L6 embrace the enzyme
molecule from both sides and exhibit distinctly different patterns of
protein-protein recognition. Comparison with a 1.7 A structure of uncomplexed
chagasin, also determined in this study, demonstrates that a conformational
change of the first binding loop (L4) allows extended binding to the non-primed
substrate pockets of the enzyme active site cleft, thereby providing a
substantial part of the inhibitory surface. The mode of chagasin binding is
generally similar, albeit distinctly different in detail, when compared to those
displayed by cystatins and the cysteine protease inhibitory p41 fragment of the
invariant chain. The chagasin-cathepsin L complex structure provides details of
how the parasite protein inhibits a host enzyme of possible importance in host
defense. The high level of structural and functional similarity between
cathepsin L and the T. cruzi enzyme cruzipain gives clues to how the cysteine
protease activity of the parasite can be targeted. This information will aid in
the development of synthetic inhibitors for use as potential drugs for the
treatment of Chagas disease.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Figure 3. Structure of the chagasin-cathepsin L complex. (a)
A ribbon stereodiagram of the complex. The inhibitor molecule is
colored gold and the enzyme blue. The surfaces of both proteins
are marked in an analogous way. The view corresponds to the
standard orientation used for cysteine proteases, along the
interface between the left (L) and right (R) domains forming the
sides of the active site cleft of cathepsin L. (b) Interaction
of chagasin in the catalytic cleft of cathepsin L, viewed
perpendicular to the standard orientation, with the L-domain
behind the inhibitor molecule and the R-domain in the front. The
side-chains of residues crucial for enzyme interactions are
represented by sticks and balls (the disordered side-chain of
K63 is shown in both alternative conformations) The enzyme is
colored blue and the framework inhibitor molecule gold, with the
enzyme-interacting loops L4, L2 and L6 in light yellow, orange
and gold, respectively. (c)–(e) Details of the enzyme
interactions of loops (c) L2, (d) L4 and (e) L6. In (c),
side-chains of the interacting residues are shown in
2F[o]–F[c] electron density contoured at the 1.2ó
level, to illustrate its quality.
|
 |
Figure 5.
Figure 5. Superposition of chagasin with the active site of
cruzipain. (a) A ribbon stereo diagram of the superposition of
the chagasin–cathepsin L complex (colored as in Figure 3(a))
with cruzipain (burgundy), after least-squares fit of the C^α
traces of the enzymes. The view is in the standard orientation
along the active site cleft of the enzymes. (b) A detailed view
of the interactions showing the central part of the chagasin
inhibitory wedge (with the L4 loop light yellow and the L2 loop
orange) and the complementary fragment of the
L-domain of cruzipain (burgundy). The side-chains of
residues crucial for the interactions are shown in
ball-and-stick representation. The synthetic inhibitor P10
([(1-(3-hydroxy-2-oxo-1-phenethyl-propylcarbamoyl)2-phenyl-ethyl]-carbamic
acid pyridin-4-ylmethyl ester), from the complex with cruzipain
(PDB code 1ME3) is shown in green.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2007,
371,
137-153)
copyright 2007.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.A.Adams-Cioaba,
J.C.Krupa,
C.Xu,
J.S.Mort,
and
J.Min
(2011).
Structural basis for the recognition and cleavage of histone H3 by cathepsin L.
|
| |
Nat Commun,
2,
197.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Renko,
J.Sabotic,
M.Mihelic,
J.Brzin,
J.Kos,
and
D.Turk
(2010).
Versatile loops in mycocypins inhibit three protease families.
|
| |
J Biol Chem,
285,
308-316.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Renko,
U.Požgan,
D.Majera,
and
D.Turk
(2010).
Stefin A displaces the occluding loop of cathepsin B only by as much as required to bind to the active site cleft.
|
| |
FEBS J,
277,
4338-4345.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.Kolodziejczyk,
K.Michalska,
A.Hernandez-Santoyo,
M.Wahlbom,
A.Grubb,
and
M.Jaskolski
(2010).
Crystal structure of human cystatin C stabilized against amyloid formation.
|
| |
FEBS J,
277,
1726-1737.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
V.Heussler,
A.Rennenberg,
and
R.Stanway
(2010).
Host cell death induced by the egress of intracellular Plasmodium parasites.
|
| |
Apoptosis,
15,
376-385.
|
 |
|
|
|
|
 |
E.T.Larson,
F.Parussini,
M.H.Huynh,
J.D.Giebel,
A.M.Kelley,
L.Zhang,
M.Bogyo,
E.A.Merritt,
and
V.B.Carruthers
(2009).
Toxoplasma gondii cathepsin L is the primary target of the invasion-inhibitory compound morpholinurea-leucyl-homophenyl-vinyl sulfone phenyl.
|
| |
J Biol Chem,
284,
26839-26850.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
I.Redzynia,
A.Ljunggren,
A.Bujacz,
M.Abrahamson,
M.Jaskolski,
and
G.Bujacz
(2009).
Crystal structure of the parasite inhibitor chagasin in complex with papain allows identification of structural requirements for broad reactivity and specificity determinants for target proteases.
|
| |
FEBS J,
276,
793-806.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.C.Goldenberg,
D.A.Iacobas,
S.Iacobas,
L.L.Rocha,
F.da Silva de Azevedo Fortes,
L.Vairo,
F.Nagajyothi,
A.C.Campos de Carvalho,
H.B.Tanowitz,
and
D.C.Spray
(2009).
Transcriptomic alterations in Trypanosoma cruzi-infected cardiac myocytes.
|
| |
Microbes Infect,
11,
1140-1149.
|
 |
|
|
|
|
 |
R.Huang,
X.Que,
K.Hirata,
L.S.Brinen,
J.H.Lee,
E.Hansell,
J.Engel,
M.Sajid,
and
S.Reed
(2009).
The cathepsin L of Toxoplasma gondii (TgCPL) and its endogenous macromolecular inhibitor, toxostatin.
|
| |
Mol Biochem Parasitol,
164,
86-94.
|
 |
|
|
|
|
 |
F.C.dos Reis,
B.O.Smith,
C.C.Santos,
T.F.Costa,
J.Scharfstein,
G.H.Coombs,
J.C.Mottram,
and
A.P.Lima
(2008).
The role of conserved residues of chagasin in the inhibition of cysteine peptidases.
|
| |
FEBS Lett,
582,
485-490.
|
 |
|
|
|
|
 |
I.Redzynia,
A.Ljunggren,
M.Abrahamson,
J.S.Mort,
J.C.Krupa,
M.Jaskolski,
and
G.Bujacz
(2008).
Displacement of the occluding loop by the parasite protein, chagasin, results in efficient inhibition of human cathepsin B.
|
| |
J Biol Chem,
283,
22815-22825.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Scharfstein,
A.C.Monteiro,
V.Schmitz,
and
E.Svensjö
(2008).
Angiotensin-converting enzyme limits inflammation elicited by Trypanosoma cruzi cysteine proteases: a peripheral mechanism regulating adaptive immunity via the innate kinin pathway.
|
| |
Biol Chem,
389,
1015-1024.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |